Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$51.4B |
| 2 |
Broadcom
AVGO
|
+$8.12B |
| 3 |
NVIDIA
NVDA
|
+$6.62B |
| 4 |
UnitedHealth
UNH
|
+$5.92B |
| 5 |
Apple
AAPL
|
+$5.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$14.9B |
| 2 |
Meta Platforms (Facebook)
META
|
+$12.7B |
| 3 |
SNDK
Sandisk
SNDK
|
+$7.89B |
| 4 |
Netflix
NFLX
|
+$6.05B |
| 5 |
Coherent
COHR
|
+$4.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.62% |
| 2 | Industrials | 10.81% |
| 3 | Communication Services | 9.9% |
| 4 | Healthcare | 9.29% |
| 5 | Financials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Phibro Animal Health
PAHC
$1.43B
| $99.2M | ﹤0.01% |
3,160,281
+987,155
| +45% | +$41.7M |
|
1227
iShares Russell 2500 ETF
SMMD
$3.81B
| $99.2M | ﹤0.01% |
1,082,560
+142,171
| +15% | +$12.2M |
|
1228
Klaviyo
KVYO
$4.77B
| $99.1M | ﹤0.01% |
6,566,155
-3,220,927
| -33% | -$53.4M |
|
1229
SM Energy
SM
$9.39B
| $99.1M | ﹤0.01% |
3,798,218
-220,198
| -5% | -$6.61M |
|
1230
Expro Ltd
XPRO
$1.93B
| $98.3M | ﹤0.01% |
6,652,271
-3,195,730
| -32% | -$51.3M |
|
1231
Sony
SONY
$140B
| $97.6M | ﹤0.01% |
4,863,244
-180,965
| -4% | -$3.81M |
|
|
TECX
1232
Tectonic Therapeutic
TECX
$564M
| $97.3M | ﹤0.01% |
2,830,378
+13,884
| +0.5% | +$408K |
|
|
ODTX
1233
Odyssey Therapeutics
ODTX
$1.07B
| $96.9M | ﹤0.01% |
+5,179,262
| New | +$90.8M |
|
1234
Aehr Test Systems
AEHR
$2.72B
| $96.7M | ﹤0.01% |
1,006,830
-1,135,809
| -53% | -$104M |
|
1235
ArriVent BioPharma
AVBP
$1.38B
| $96.5M | ﹤0.01% |
2,778,959
-237,173
| -8% | -$7M |
|
1236
First Interstate BancSystem
FIBK
$3.58B
| $95M | ﹤0.01% |
2,463,971
-1,413,225
| -36% | -$50M |
|
|
BCPC
1237
Balchem Corp
BCPC
$5.33B
| $94.7M | ﹤0.01% |
560,255
-38,415
| -6% | -$6.38M |
|
1238
Avalo Therapeutics
AVTX
$859M
| $94.3M | ﹤0.01% |
5,100,216
+2,220,735
| +77% | +$35.1M |
|
1239
Genworth Financial
GNW
$3.84B
| $93.8M | ﹤0.01% |
9,907,039
+2,233,722
| +29% | +$19.9M |
|
1240
Southern Copper
SCCO
$162B
| $93.2M | ﹤0.01% |
541,319
-61,537
| -10% | -$11.1M |
|
1241
Frontdoor
FTDR
$5.59B
| $92.9M | ﹤0.01% |
1,197,710
-712,851
| -37% | -$45.6M |
|
1242
Owens Corning
OC
$10.2B
| $92.9M | ﹤0.01% |
584,425
+166,783
| +40% | +$20.3M |
|
1243
Zions Bancorporation
ZION
$9.82B
| $92.8M | ﹤0.01% |
1,341,623
+400,041
| +42% | +$25.2M |
|
1244
Prudential
PUK
$32.8B
| $92.8M | ﹤0.01% |
3,461,802
-599,561
| -15% | -$17.5M |
|
1245
Brookdale Senior Living
BKD
$2.85B
| $92.8M | ﹤0.01% |
5,764,800
+1,166,184
| +25% | +$15.9M |
|
1246
Houlihan Lokey
HLI
$9.32B
| $92.7M | ﹤0.01% |
690,813
-165,211
| -19% | -$24.4M |
|
1247
IMAX
IMAX
$2.89B
| $92.6M | ﹤0.01% |
2,322,400
-794,974
| -26% | -$30.5M |
|
|
OGC
1248
OceanaGold Corp
OGC
$6.43B
| $92.2M | ﹤0.01% |
+3,677,898
| New | +$110M |
|
1249
Acushnet Holdings
GOLF
$4.85B
| $92.1M | ﹤0.01% |
776,963
+318,248
| +69% | +$30.4M |
|
1250
Invesco FTSE RAFI Emerging Markets ETF
PXH
$2.08B
| $91.9M | ﹤0.01% |
3,296,679
+16,928
| +0.5% | +$483K |
|
Similar funds
Fidelity Investments's Q2 2026 Portfolio in Review
As of Q2 2026, Fidelity Investments held 5,773 positions worth $2.3T, up 21% from $1.9T the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Fidelity Investments's Q2 2026 filing shows 351 new, 2,921 increased, 1,859 reduced and 211 closed positions. Its largest new stake was SpaceX: 302,555,831 shares worth $51.7B. The largest sale was Marvell Technology, an estimated $14.9B.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 32% a quarter earlier, followed by Industrials and Communication Services.
- Fidelity Investments's largest Q2 2026 buy was SpaceX: 302,555,831 shares worth $51.7B.
- Fidelity Investments added most to Broadcom in Q2 2026, an estimated $8.12B increase.
- Fidelity Investments's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $14.9B.
- Fidelity Investments fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $272M.
- Fidelity Investments's ten largest holdings make up 34% of its $2.3T portfolio in Q2 2026.
- Fidelity Investments opened 351 new positions and closed 211 in Q2 2026.
- Fidelity Investments's portfolio value rose 21% quarter-over-quarter to $2.3T.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.